Albert David Limited
Albert David Limited announced the appointment of Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla, a seasoned leader with over 28 years of experience, is recognized for transforming underperforming businesses into high-growth engines across leading pharmaceutical organizations.
May 13 2026 17:05:00
Albert David Limited
Albert David Limited announced the appointment of Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla, a seasoned leader with over 28 years of experience, is recognized for transforming underperforming businesses into high-growth engines across leading pharmaceutical organizations.
May 13 2026 17:05:00
Albert David Ltd-$ - 524075 - Integrated Filing Financials For The Fourth Quarter And Year Ended 31St March 2026
Albert David announced its Q4 and full-year FY26 audited financial results. The company's net profit for FY26 turned into a loss of Rs.1.49 crore, and total income declined 9% YoY to Rs.341.05 crore. Despite the financial performance, the board recommended a final dividend of Rs.5 per share for FY26.
May 13 2026 16:05:00
Albert David Ltd-$ - 524075 - KMP''s Authorised To Determine Materiality Under Regulation 30(5) Of SEBI(LODR),2015
Albert David has appointed Mr. Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla is a seasoned leader with over 28 years of experience in the pharmaceutical sector, including stints at Cipla, Glenmark, and JB Pharma.
May 12 2026 20:05:00
Albert David Ltd-$ - 524075 - Record Date Fixed On 30Th July 2026 For The Purpose Of Final Dividend And Determining Members Eligible To Vote For 87Th AGM.
Albert David has appointed Mr. Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla is a seasoned leader with over 28 years of experience in the pharmaceutical sector, including stints at Cipla, Glenmark, and JB Pharma.
May 12 2026 20:05:00
Albert David Ltd-$ - 524075 - Re-Appointment Of Cost Auditors For The F.Y. 2026-27
Albert David has appointed Mr. Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla is a seasoned leader with over 28 years of experience in the pharmaceutical sector, including stints at Cipla, Glenmark, and JB Pharma.
May 12 2026 19:05:00
Albert David Ltd-$ - 524075 - Re-Appointment Of Internal Auditors For The F.Y. 2026-27
Albert David has appointed Mr. Amit Mahla as its new Chief Executive Officer, effective May 12, 2026. Mahla is a seasoned leader with over 28 years of experience in the pharmaceutical sector, including stints at Cipla, Glenmark, and JB Pharma.
May 12 2026 19:05:00
Albert David Ltd-$ - 524075 - Board Meeting Intimation for Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure
Requirements) Regulations, 2015
Albert David's Board will convene on May 12, 2026, to consider and approve the audited financial results for Q4 and the full financial year ended March 31, 2026. They will also consider recommending a final dividend.
May 04 2026 15:05:00
Read More